Doctor's Notes

Negative Patch Tests Across 31,948 Suspected-Dermatitis Patients

Fictional illustration of an adult female clinical analyst reviewing anonymized patch-test records with the authentic Dr. Arsy #003 4 oz jar

Doctor’s Notes · Life in Motion · Primary-Study Review

Visual disclosure: The featured image is an AI-created illustration of a fictional adult workplace or activity scene combined with the authentic Dr. Arsy #003 packshot. It is not a patient, study participant, endorsement, diagnosis, before-and-after image or product result.

The exact question: What did PMID 42652911 measure in 31,948 patients evaluated for suspected allergic contact dermatitis from 1997 through 2023., and what would go beyond the evidence?

Why this matters in a moving day

An adult female clinical analyst reviewing anonymized patch-test records is a specific context, not a diagnosis. Work pace, equipment, wetness, friction, climate, ultraviolet exposure, sleep and prior skin history can overlap. The paper below answers one narrow question; it does not turn every similar setting into the same outcome.

Study snapshot

Study element Reported detail
Population / denominator 31,948 patients evaluated for suspected allergic contact dermatitis from 1997 through 2023.
Design Retrospective patch-test database analysis with standardized questionnaire, examination and multivariable regression.
Comparator Occupational groups, body sites and exposure patterns among patch-tested patients.
Timepoint Twenty-seven years of database records.
Numerical finding 43.4% had negative patch tests; 30.9% had hand involvement, and negative tests were less common with hand disease (OR 0.936, 95% CI 0.892–0.981).
Funding / conflicts The PubMed abstract does not state funding or conflicts.

What the study found

43.4% had negative patch tests; 30.9% had hand involvement, and negative tests were less common with hand disease (OR 0.936, 95% CI 0.892–0.981).

A negative patch test does not mean no dermatitis; it narrows evidence about tested allergic sensitization in a referred population.

The denominator is part of the result. A survey, clinical examination, environmental sample, instrument reading, case report and case-control estimate answer different questions. A reported symptom is not automatically a confirmed diagnosis, and a physiological change is not automatically disease.

Important limitations

Referral selection, long calendar period, changing practice and exposure coding; the published cook confidence interval appears internally inconsistent and is not repeated here.

These limitations do not erase the observation; they set its boundaries. Null results and uncertainty are retained because removing them would change the study’s meaning.

How to read the denominator, comparator and timepoint

The evidence base here is 31,948 patients evaluated for suspected allergic contact dermatitis from 1997 through 2023. The study design was retrospective patch-test database analysis with standardized questionnaire, examination and multivariable regression. Its comparison was occupational groups, body sites and exposure patterns among patch-tested patients. That combination determines what the numbers can answer. A result from this population should not be silently expanded to every worker, athlete, parent or person with sensitive skin, and an association should not be rewritten as proof of cause.

The reported time frame was twenty-seven years of database records. That matters because a single assessment, short intervention, long follow-up and case report each capture different parts of a moving routine. For an adult female clinical analyst reviewing anonymized patch-test records, the defensible use of this evidence is to observe the same concrete variables the researchers measured—task, exposure, fit, timing or environment—while keeping the original uncertainty visible. It is not evidence that a moisturizer changes the study outcome.

A careful decision boundary

The numerical result was: 43.4% had negative patch tests; 30.9% had hand involvement, and negative tests were less common with hand disease (OR 0.936, 95% CI 0.892–0.981). The practical question is therefore not “Does this prove the job or activity causes a skin condition?” It is “What was observed in this defined group, under this comparison, at this timepoint?” That narrower question preserves both positive and null findings. It also helps separate routine dry-skin comfort from occupational disease, allergy, infection, ultraviolet injury or another condition that may require exposure control or professional assessment.

A practical observation log

  • Record the exact task, surface, garment, equipment, weather or room condition.
  • Note the body site and whether the pattern matches pressure, friction, wet work or exposure.
  • Record timing: before the shift, during the activity, after washing and after recovery.
  • Separate a visible sign from a sensation and from a clinician’s diagnosis.
  • Document changes in fit, cleaning products, protective equipment, workload, sleep or environment.

What this paper does not show

It does not show that every person in the same job or activity will have the reported outcome. It does not establish that Dr. Arsy #003 was studied, and it does not support substituting moisturizer for exposure control, fit correction, sun protection, infection precautions or medical assessment.

Primary and authoritative sources

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. PMID 42652911 did not test #003. The study cannot be used to claim that #003 treats, cures or prevents eczema, allergy, infection, sun injury, occupational disease or cancer; relieves pain or itch; works for everyone; is proven safe for children; or provides unverified 24-hour protection.

Continue the Life in Motion evidence series

Search context: The campaign keyword workbook is used only as site-impression context; no market-wide search volume or ranking is claimed.

Educational evidence review, not individual medical advice or activity clearance. PubMed indexing is not NIH endorsement.

← Back to Doctor's Notes